Editorial: LncRNA and their role on epigenome in cancer

Qi Su; Francesca Maria Orlandella; Giovanni Smaldone; Yitao Qi

doi:10.3389/fmolb.2024.1533057

Editorial: LncRNA and their role on epigenome in cancer

Front Mol Biosci. 2024 Dec 4:11:1533057. doi: 10.3389/fmolb.2024.1533057. eCollection 2024.

Authors

Qi Su¹, Francesca Maria Orlandella², Giovanni Smaldone³, Yitao Qi¹

Affiliations

¹ Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest China, College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi, China.
² University of Naples Parthenope, Naples, Italy.
³ IRCCS SYNLAB SDN, Naples, Italy.

No abstract available

Keywords: biomarkers; cancer; epigenetic; gene editing technology; gene therapy; lncRNA.

Publication types

Editorial

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. We thank the grants from the National Natural Science Foundation of China (81870241, 82273395, and 82203387), the Fundamental Research Funds for the Central Universities (GK202202006, GK202207003), the Shaanxi Province Postdoctoral Science Foundation (2023BSHYDZZ117), the Excellent Graduate Training Program of Shaanxi Normal University (LHRCTS23089, LHRCCX23174), the Macao Youth Scholars Program (AM2022017), and the grant of the Italian Ministry of Health (GR-2021-12372945).